Glyco-engineered CHO Cell Lines Producing Alpha-1 ... - PubMed

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Recombinant Chinese hamster ovary (CHO) cells are able to provide biopharmaceuticals that are essentially free of human viruses and have N-glycosylation profiles similar, but not identical, to humans. Due to differences in N-glycan moieties, two members of the serpin superfamily, alpha-1-antitrypsin (A1AT) and plasma protease C1 inhibitor (C1INH), are currently derived from human plasma for treating A1AT and C1INH deficiency. Deriving therapeutic proteins from human plasma is generally a cost-intensive process and also harbors a risk of transmitting infectious particles. Recombinantly produced A1AT and C1INH (rhA1AT, rhC1INH) decorated with humanized N-glycans are therefore of clinical and commercial interest. Here, we present engineered CHO cell lines producing rhA1AT or rhC1INH with fully humanized N-glycosylation profiles. This was achieved by combining CRISPR/Cas9-mediated disruption of 10 gene targets with overexpression of human ST6GAL1. We were able to show that the N-linked glyco-structures of rhA1AT and rhC1INH are homogeneous and similar to the structures obtained from plasma-derived A1AT and C1INH, marketed as Prolastin®-C and Cinryze®, respectively. rhA1AT and rhC1INH produced in our glyco-engineered cell line showed no detectable differences to their plasma-purified counterparts on SDS-PAGE and had similar enzymatic in vitro activity. The work presented here shows the potential of expanding the glyco-engineering toolbox for CHO cells to produce a wider variety of glycoproteins with fully humanized N-glycan profiles. We envision replacing plasma-derived A1AT and C1INH with recombinant versions and thereby decreasing our dependence on human donor blood, a limited and possibly unsafe protein source for patients.

Keywords: Biotechnology; CRISPR/Cas9; Chinese hamster ovary (CHO) cells; Glyco-engineering; Multiplexing; Plasma proteins.

Copyright © 2018 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Animals Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, CD / biosynthesis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, CD / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CHO Cells / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CRISPR-Cas Systems Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Complement C1 Inhibitor Protein / biosynthesis* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cricetinae Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cricetulus Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glycosylation Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Metabolic Engineering / methods* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Recombinant Proteins / biosynthesis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sialyltransferases / biosynthesis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sialyltransferases / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• alpha 1-Antitrypsin / biosynthesis* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• beta-D-Galactoside alpha 2-6-Sialyltransferase Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antigens, CD Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Complement C1 Inhibitor Protein Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Recombinant Proteins Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sialyltransferases Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• alpha 1-Antitrypsin Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• ST6GAL1 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• beta-D-Galactoside alpha 2-6-Sialyltransferase Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program